Should you buy Innoviva (INVA)?
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Engine methodology range
Range computation requires sufficient peer-comparable data; available for tickers with peer_count ≥3.
What the engine is tracking
- Cyclical Earnings Contraction RiskTripped↑Improving
- High Quality Moat Execution→Stable
- Fcf Earnings Divergence→Stable
- +2 more pillars — see the Why tab for full reasoning
→ Full pillar scorecard with all 5 pillars + per-dimension breakdown
When this thesis breaks
Falsifiable conditions per pillar — any one trip warrants review independent of price action. Engine-derived; not personalized advice.
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Cyclical Earnings Contraction RiskTripped
Trip ifForward P/E compresses below 6x as earnings estimates are revised upward, indicating the feared 65% contraction is not materializing.
- P2High Quality Moat Execution
Trip ifThree consecutive quarters of earnings misses (EPS surprise below 0%), reversing the established beat pattern.
- P3Fcf Earnings Divergence
Trip ifFree cash flow rises above 60% of net income for 2 consecutive quarters, resolving the earnings conversion concern.
- P4Attractive Valuation With UpsideTripped
Trip ifAnalyst consensus target falls below $25.00, reducing implied upside below 12% from the current price of $22.42.
- P5Csuite Change Governance Flag
Trip ifTwo consecutive quarterly earnings beats (EPS surprise above 5%) post-transition confirm leadership continuity has not disrupted operations.
How the engine reached this verdict
TrendMatrix's engine output for Innoviva, Inc. (INVA) is STRONG_BUY_NOW with high conviction, score 6.8/10 at $21.24. The engine's BUY_NOW gates are all passing and the asymmetry favors initiating rather than waiting for a pullback.
The engine's suggested entry is $21.25 (current $21.24), target $29.75 (+40%), stop $20.47. Asymmetric reward-to-risk is 8.00. The engine's sizing output: 2.0% of portfolio at this asymmetry level (high-conviction tier).
On the bull side: V7 quality resilience bonus: +0.2 (Q=7.8 in RISK_OFF); Sector modifier (Healthcare): +0.5; Strong earnings beat streak (3/4). On the bear side: Cyclical risk: PE expanding 2.0x (earnings normalizing).
The closest gate to its boundary is momentum at 5.4 vs threshold 5.5. A flip to BUY_WAIT requires either a gate slipping below its threshold or asymmetry R:R compressing below 2.0.
For the full 10-dimension breakdown + V9 gate detail: Why TrendMatrix rates INVA — 10-dimension breakdown →
Bull case
- ▸V7 quality resilience bonus: +0.2 (Q=7.8 in RISK_OFF)
- ▸Sector modifier (Healthcare): +0.5
- ▸Strong earnings beat streak (3/4)
Bear case
- ▸Cyclical risk: PE expanding 2.0x (earnings normalizing)